Rakuten Medical and Shimadzu Enroll First Patient in the U.S. Clinical Trial of Photoimmunotherapy- Phase 2 Clinical Trial, ASP-1929 Photoimmunotherapy with Fluorescence Imaging for Operable Primary or Recurrent Head and Neck or Cutaneous Squamous Cell Carcinoma –